This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Hits 52-Week High on Solid Results, SCAI Deal
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) touched a 52-week highdriven by robust fourth-quarter earnings, strong 2017 guidance and the acquisition of Surgical Care.
Community Health Sells Hospitals & Assets to Steward Health
by Zacks Equity Research
Community Health Systems, Inc. (CYH) recently announced that its subsidiaries have signed a definitive agreement with Steward Health Care LLC to sell eight hospitals and their associated assets to the subsidiaries of the later.
Bet on These 5 Low Leverage Stocks for Safe Returns
by Zacks Equity Research
Debt-ridden companies are prone to bankruptcy in times of financial crisis. So it is imperative that a sensible investor will choose stocks bearing low debt-to-equity ratios.
HCA Holdings (HCA) Q4 Earnings Beat, Revenues Miss
by Zacks Equity Research
HCA Holdings Inc. (HCA) reported fourth-quarter 2016 adjusted earnings of $1.89 per share, which beat the Zacks Consensus Estimate of $1.78 by 6.2%.
Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Becton, Dickinson and Company (BDX) is set to report first-quarter fiscal 2017 earnings results on Feb 2.
Will PerkinElmer (PKI) Disappoint this Earnings Season?
by Zacks Equity Research
PerkinElmer Inc. (PKI) is expected to report fourth-quarter 2016 results on Feb 2, 2017.
Will Baxter International (BAX) Disappoint in Q4 Earnings?
by Zacks Equity Research
Baxter International Inc. (BAX) is scheduled to report fourth-quarter 2016 earnings on Feb 1, before the opening bell.
Henry Schein (HSIC) Q4 Earnings: Disappointment in Store?
by Zacks Equity Research
Henry Schein, Inc. (HSIC) is expected to report fourth-quarter 2016 financial numbers on Feb 8, before the opening bell.
Is it the Right Time to Offload LifePoint Health (LPNT) Stock?
by Zacks Equity Research
LifePoint Health Inc. (LPNT) seems to have fallen on hard times due to multiple headwinds like unprofitable acquisitions, decline in enrollment and rising level of bad debts over the last few years.
AmerisourceBergen (ABC) Q1 Earnings: Will It Disappoint?
by Zacks Equity Research
AmerisourceBergen Corp. (ABC) is set to report first-quarter fiscal 2017 results on Jan 31, before the opening bell.
C.R. Bard (BCR) to Report Q4 Earnings: A Surprise in Store?
by Zacks Equity Research
Delving deeper into the fundamentals of C.R. Bard (BCR), let's see how things are shaping up prior to this quarter.
Is a Surprise in Store for Hologic (HOLX) in Q1 Earnings?
by Zacks Equity Research
Hologic Inc. (HOLX) is slated to report first-quarter fiscal 2017 financial results on Feb 1, after the closing bell.
Myriad Genetics (MYGN) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Myriad Genetics, Inc.(MYGN) is expected to report second-quarter fiscal 2017 results on Feb 7, after the closing bell.
Is Universal Health (UHS) a Great Stock for Value Investors?
by Zacks Equity Research
Let's find out if Universal Health Services, Inc. (UHS) stock is a good choice for value-oriented investors.
Why You Should Hold onto Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Shares of Acadia Healthcare Company, Inc. (ACHC), have recently gained momentum. Month to date, the stock has returned 15.4% compared with the Zacks categorized Hospitals industry's increase of 10.8%.
Buy these 5 Low Leverage Stocks to Be Safe
by Zacks Equity Research
Considering the fact that debt ridden companies are more vulnerable at times of volatility, it is safe to avoid those for achieving optimal returns.
IDEXX Laboratories (IDXX) Q4 Earnings: What's in Store?
by Zacks Equity Research
IDEXX Laboratories, Inc. (IDXX) is slated to report fourth-quarter 2016 results on Feb 2, before the opening bell.
Will Boston Scientific (BSX) Pull a Surprise in Q4 Earnings?
by Zacks Equity Research
Boston Scientific Corporation (BSX) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Feb 2.
Edward Lifesciences (EW): What's in Store in Q4 Earnings?
by Zacks Equity Research
Edward Lifesciences Corp. (EW) is scheduled to report fourth-quarter and full-year 2016 earnings results after market close on Feb 1, 2017.
Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?
by Zacks Equity Research
Thermo Fisher Scientific, Inc. (TMO) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Jan 31.
Illumina (ILMN) Q4 Earnings: A Beat in Store for the Stock?
by Zacks Equity Research
We expect Illumina Inc (ILMN) to beat expectations when it reports fourth-quarter 2016 results after the closing bell on Jan 31.
Boost Your Portfolio by Betting on Stocks with Rising P/E
by Zacks Equity Research
Inside the top-ranked stocks that can beat earnings estimates in their next releases.
Can HCA Holdings Retain its Business Strength in 2017?
by Zacks Equity Research
While HCA Holdings (HCA) gave a strong outlook for its top and bottom lines, details on admission in the fourth quarter were not so appealing.
HCA Holdings Holds Promise Despite Headwinds: Here's Why
by Zacks Equity Research
The uptrend in HCA Holdings Inc. (HCA) explains its attractiveness in an uncertainty-ridden industry.
HCA Holdings Well Poised for Growth In Spite of Headwinds
by Zacks Equity Research
HCA Holdings (HCA) scale and diversified business mix provides it a competitive advantage.